Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The procurement project was seeking to lease laboratory equipment and to purchase consumables / reagents which will deliver an evaluative implementation of Non-Invasive Prenatal Testing(NIPT) as a second line screen for the first and second trimester trisomy 21, 13 and 18 screening programme.
It aims to provide a better patient experience by improving the diagnostic performance of the screen with the offer of NIPT as a second line screen.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Illumina Cambridge Ltd | 03625145 | ~£900,000 estimated from lot values | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 1,080 days (≈3 yrs) | £900,000 £940,000 initial term | 1 single bid — no competition | Illumina Cambridge Ltd | complete |
Weightings from the notice.
Government spending data: This supplier has received £40,779,951 in 776 payments (over £25k) from UK Health Security Agency, Manchester University NHS Foundation Trust, DEFRA, Guy's and St Thomas' NHS FT, UKRI and 3 more public bodies (2018-03-30 to 2026-05-11). View full payment history →
Published by the buyer on this notice. Check the original notice — details change and are not updated here.